Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.39

-1.9%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2687)	2/2/2010 3:03:38 PM
From: Jibacoa	Read Replies (1) of 3722

ATHX was up 18.48% at its intraday H and is still up 12.77% but has continued to drift down as I am writing.<g> Volume of 1,297,700 is still about half its ADV. bigcharts.marketwatch.com ATHX nnounced today that its CEO, Dr. Gil Van Bokkelen, will present at the 12th Annual BIO CEO & Investor Conference to be held at the Waldorf, Feb8-9. The conference will provide a forum to discuss breakthrough therapeutic developments and issues that affect the biotech industry. The stock is trying to get off from its near term DT after the spike in Dec to the $6.40 level.<g> bigcharts.marketwatch.com ATX has been trimming its loss in the last 3Qs in spite of lower revenues. It has NLTD and the insiders reportedly hold > 35% of the stock. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next